These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33469789)

  • 1. Effects of the dopamine transporter gene on neuroimaging findings in different attention deficit hyperactivity disorder presentations.
    Bacanlı A; Unsel-Bolat G; Suren S; Yazıcı KU; Callı C; Aygunes Jafari D; Kosova B; Rohde LA; Ercan ES
    Brain Imaging Behav; 2021 Apr; 15(2):1103-1114. PubMed ID: 33469789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.
    Bédard AC; Schulz KP; Cook EH; Fan J; Clerkin SM; Ivanov I; Halperin JM; Newcorn JH
    Neuroimage; 2010 Nov; 53(3):935-42. PubMed ID: 20026227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter genotype modulates brain activity during a working memory task in children with ADHD.
    Pineau G; Villemonteix T; Slama H; Kavec M; Balériaux D; Metens T; Baijot S; Mary A; Ramoz N; Gorwood P; Peigneux P; Massat I
    Res Dev Disabil; 2019 Sep; 92():103430. PubMed ID: 31306870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical thickness differences in the prefrontal cortex in children and adolescents with ADHD in relation to dopamine transporter (DAT1) genotype.
    Fernández-Jaén A; López-Martín S; Albert J; Fernández-Mayoralas DM; Fernández-Perrone AL; de La Peña MJ; Calleja-Pérez B; Rodríguez MR; López-Arribas S; Muñoz-Jareño N
    Psychiatry Res; 2015 Sep; 233(3):409-17. PubMed ID: 26206710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.
    Durston S; Fossella JA; Mulder MJ; Casey BJ; Ziermans TB; Vessaz MN; VAN Engeland H
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):61-67. PubMed ID: 18174826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the dopamine transporter gene on striatal functional connectivity in youths with attention-deficit/hyperactivity disorder.
    Shang CY; Lin HY; Gau SS
    Psychol Med; 2021 Apr; 51(5):835-845. PubMed ID: 31907092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder.
    Brown AB; Biederman J; Valera EM; Doyle AE; Bush G; Spencer T; Monuteaux MC; Mick E; Whitfield-Gabrieli S; Makris N; LaViolette PS; Oscar-Berman M; Faraone SV; Seidman LJ
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):365-375. PubMed ID: 19676101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks.
    Brown AB; Biederman J; Valera E; Makris N; Doyle A; Whitfield-Gabrieli S; Mick E; Spencer T; Faraone S; Seidman L
    Psychiatry Res; 2011 Jul; 193(1):7-16. PubMed ID: 21596533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD.
    Braet W; Johnson KA; Tobin CT; Acheson R; McDonnell C; Hawi Z; Barry E; Mulligan A; Gill M; Bellgrove MA; Robertson IH; Garavan H
    Neuropsychologia; 2011 Jun; 49(7):1641-50. PubMed ID: 21232548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of DAT1 and COMT variants on neural activation during response inhibition in adolescents with attention-deficit/hyperactivity disorder and healthy controls.
    van Rooij D; Hoekstra PJ; Bralten J; Hakobjan M; Oosterlaan J; Franke B; Rommelse N; Buitelaar JK; Hartman CA
    Psychol Med; 2015 Nov; 45(15):3159-70. PubMed ID: 26073896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants of the SLC6A3 (DAT1) polymorphism affect performance monitoring-related cortical evoked potentials that are associated with ADHD.
    Althaus M; Groen Y; Wijers AA; Minderaa RB; Kema IP; Dijck JD; Hoekstra PJ
    Biol Psychol; 2010 Sep; 85(1):19-32. PubMed ID: 20450954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of DAT1 genotype on fMRI activation in an emotional go/no-go task.
    Brown BK; Murrell J; Karne H; Anand A
    Brain Imaging Behav; 2017 Feb; 11(1):185-193. PubMed ID: 26843006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder.
    Sonuga-Barke EJ; Oades RD; Psychogiou L; Chen W; Franke B; Buitelaar J; Banaschewski T; Ebstein RP; Gil M; Anney R; Miranda A; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Thompson M; Asherson P; Faraone SV
    J Child Psychol Psychiatry; 2009 Sep; 50(9):1052-63. PubMed ID: 19490304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional brain network organization distinguishes the combined and inattentive subtypes of Attention Deficit Hyperactivity Disorder.
    Saad JF; Griffiths KR; Kohn MR; Clarke S; Williams LM; Korgaonkar MS
    Neuroimage Clin; 2017; 15():383-390. PubMed ID: 28580295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Inci Kenar AN; Ünal GA; Güler H; Albuz B; Kıroğlu Y; Erdal ME; Herken H
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1373-8. PubMed ID: 27097961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A haplotype of the dopamine transporter gene modulates regional homogeneity, gray matter volume, and visual memory in children with attention-deficit/hyperactivity disorder.
    Shang CY; Lin HY; Tseng WY; Gau SS
    Psychol Med; 2018 Nov; 48(15):2530-2540. PubMed ID: 29433615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAT1 3'-UTR 9R allele: preferential transmission in Indian children with attention deficit hyperactivity disorder.
    Das M; Mukhopadhyay K
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):826-9. PubMed ID: 17440935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.